Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 11:57 PM
Ignite Modification Date: 2025-12-24 @ 11:57 PM
NCT ID: NCT05169151
Eligibility Criteria: Inclusion Criteria: * Patients age 15-39 at the time of study entry * Patients must be within 3 weeks of starting anti-cancer therapy * Patients must have a diagnosis of Hodgkin lymphoma, non-Hodgkin lymphoma, sarcoma and have plans to receive anthracyclines or radiation therapy to the chest OR * have a diagnosis of a central nervous system (CNS) tumor OR * have plans to receive a stem cell transplant * Patients must have smartphone device and regular access to internet * Patients must be English-speaking Exclusion Criteria: * Patients that are a ward of the state
Healthy Volunteers: False
Sex: ALL
Minimum Age: 15 Years
Maximum Age: 39 Years
Study: NCT05169151
Study Brief:
Protocol Section: NCT05169151